ARRY
TD Asset Management’s Array Biopharma Inc ARRY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-40,064
| Closed | -$1.86M | – | 1395 |
|
|
2019
Q2 | $1.86M | Sell |
40,064
-204,697
| -84% | -$9.48M | ﹤0.01% | 921 |
|
|
2019
Q1 | $5.97M | Buy |
244,761
+98,812
| +68% | +$2.41M | 0.01% | 649 |
|
|
2018
Q4 | $2.08M | Buy |
145,949
+35,500
| +32% | +$506K | ﹤0.01% | 906 |
|
|
2018
Q3 | $1.68M | Sell |
110,449
-10,700
| -9% | -$163K | ﹤0.01% | 1039 |
|
|
2018
Q2 | $2.03M | Buy |
121,149
+1,100
| +0.9% | +$18.5K | ﹤0.01% | 953 |
|
|
2018
Q1 | $1.96M | Buy |
120,049
+43,600
| +57% | +$711K | ﹤0.01% | 892 |
|
|
2017
Q4 | $979K | Sell |
76,449
-7,500
| -9% | -$96K | ﹤0.01% | 1056 |
|
|
2017
Q3 | $1.03M | Buy |
83,949
+33,065
| +65% | +$407K | ﹤0.01% | 1021 |
|
|
2017
Q2 | $426K | Sell |
50,884
-61,484
| -55% | -$515K | ﹤0.01% | 1212 |
|
|
2017
Q1 | $1.01M | Buy |
112,368
+4,500
| +4% | +$40.2K | ﹤0.01% | 1035 |
|
|
2016
Q4 | $948K | Buy |
+107,868
| New | +$948K | ﹤0.01% | 1039 |
|
|
2015
Q4 | – | Sell |
-222,100
| Closed | -$1.01M | – | 1401 |
|
|
2015
Q3 | $1.01M | Sell |
222,100
-88,700
| -29% | -$405K | ﹤0.01% | 920 |
|
|
2015
Q2 | $2.24M | Sell |
310,800
-19,600
| -6% | -$141K | ﹤0.01% | 836 |
|
|
2015
Q1 | $2.44M | Sell |
330,400
-9,300
| -3% | -$68.5K | ﹤0.01% | 807 |
|
|
2014
Q4 | $1.61M | Buy |
339,700
+12,400
| +4% | +$58.7K | ﹤0.01% | 863 |
|
|
2014
Q3 | $1.17M | Sell |
327,300
-11,200
| -3% | -$40K | ﹤0.01% | 881 |
|
|
2014
Q2 | $1.54M | Sell |
338,500
-23,800
| -7% | -$109K | ﹤0.01% | 854 |
|
|
2014
Q1 | $1.7M | Buy |
362,300
+28,800
| +9% | +$135K | ﹤0.01% | 847 |
|
|
2013
Q4 | $1.67M | Buy |
333,500
+6,300
| +2% | +$31.6K | ﹤0.01% | 832 |
|
|
2013
Q3 | $2.04M | Buy |
327,200
+103,100
| +46% | +$641K | ﹤0.01% | 799 |
|
|
2013
Q2 | $1.02M | Buy |
+224,100
| New | +$1.02M | ﹤0.01% | 843 |
|